BAM-1110
BAM-1110 is a dopamine receptor agonist. BAM-1110 exhibits dose-dependent antiparkinsonian activity in MPTP (HY-W114750) -treated monkey models of Parkinson's disease. BAM-1110 has minimal side effects and can be used for the research of Parkinson's disease and other neurological disorders[1].
Product Specifications
CAS Number
[155210-57-4]
UNSPSC
12352005
Target
Dopamine Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
OC(/C=C\C(O)=O)=O.CN1[C@@]2([H])[C@@](C[C@H](C1)CN3C=NC=N3)([H])C4=CC=CC5=C4C(C2)=CN5.[x]
Molecular Formula
C18H21N5.xC4H4O4
Molecular Weight
307.39 (free base)
References & Citations
[1]Kuno S, et al. Antiparkinsonian effects of BAM-1110, a novel ergoline derivative, in MPTP-treated cynomolgus monkeys. Clin Neuropharmacol. 1998 Jan-Feb;21 (1) :35-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
138283-PE 100 µL
RARRES3 (Retinoic Acid Receptor Responder Protein 3, RAR-responsive Protein TIG3, Retinoid-inducible Gene 1 Protein, Tazarotene-induced Gene 3 Protein, RIG1, TIG3, MGC8906) (PE)
Ask
View Details GTR15138429 1 Vial
Lentiviral human CCL20 shRNA (UAS) - Lentiviral human CCL20 shRNA (UAS, GFP) (100)
Ask
View Details 
MBS1194558-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YER186C (YER186C)
Ask
View Details MBS1194558-02 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YER186C (YER186C)
Ask
View Details MBS1194558-03 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YER186C (YER186C)
Ask
View Details MBS1194558-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YER186C (YER186C)
Ask
View Details